Fatty acids, lipid metabolism and Alzheimer pathology

被引:84
作者
Hooijmans, Carlijn R.
Kiliaan, Amanda J. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Anat, NL-6500 HB Nijmegen, Netherlands
关键词
omega-3 fatty acids; cholesterol; apolipoprotein E (ApoE); Alzheimer's disease; vascular risk factors; pathology;
D O I
10.1016/j.ejphar.2007.11.081
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alzheimer's disease is the most common form of dementia in the elderly. The cause of Alzheimer's disease is still unknown and there is no cure for the disease yet despite 100 years of extensive research. Cardiovascular risk factors such as high serum cholesterol, presence of the Apolipoprotein epsilon 4 (APOE epsilon 4) allele and hypertension, play important roles in the development of Alzheimer's disease. We postulate that a combination of diet, lifestyle, vascular, genetic, and amyloid related factors, which enhance each other's contribution in the onset and course of Alzheimer's disease, will be more likely the cause of the disease instead of one sole mechanism. The possibility that the risk for Alzheimer's disease can be reduced by diet or lifestyle is of great importance and suggests a preventative treatment in Alzheimer's disease. Because of the great importance of lipid diets and metabolism in preventative treatment against both Alzheimer's disease and cardiovascular disease, long-chain polyunsaturated fatty acids from fish oil, ApoE genotype and cholesterol metabolism in correlation with Alzheimer's disease will be reviewed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:176 / 196
页数:21
相关论文
共 306 条
  • [41] Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions
    Cole, GM
    Lim, GP
    Yang, FS
    Teter, B
    Begum, A
    Ma, QL
    Harris-White, ME
    Frautschy, SA
    [J]. NEUROBIOLOGY OF AGING, 2005, 26 : S133 - S136
  • [42] Connor WE, 2000, AM J CLIN NUTR, V71, p171S, DOI 10.1093/ajcn/71.1.171S
  • [43] Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
    Conquer, JA
    Tierney, MC
    Zecevic, J
    Bettger, WJ
    Fisher, RH
    [J]. LIPIDS, 2000, 35 (12) : 1305 - 1312
  • [44] PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE
    CORDER, EH
    SAUNDERS, AM
    RISCH, NJ
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    RIMMLER, JB
    LOCKE, PA
    CONNEALLY, PM
    SCHMADER, KE
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. NATURE GENETICS, 1994, 7 (02) : 180 - 184
  • [45] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [46] Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein
    Cordy, JM
    Hussain, I
    Dingwall, C
    Hooper, NM
    Turner, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) : 11735 - 11740
  • [47] Fish consumption and the 30-year risk of fatal myocardial infarction
    Daviglus, ML
    Stamler, J
    Orencia, AJ
    Dyer, AR
    Liu, K
    Greenland, P
    Walsh, MK
    Morris, D
    Shekelle, RB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1046 - 1053
  • [48] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21
  • [49] Alzheimer neuropathologic alterations in aged cognitively normal subjects
    Davis, DG
    Schmitt, FA
    Wekstein, DR
    Markesbery, WR
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (04) : 376 - 388
  • [50] Alzheimer's disease: How does it start?
    de la Torre, J. C.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (06) : 497 - 512